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Cystadenofibroma of the rete ovarii: a case report with review of literature
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Introduction
The rete ovarii (RO), the homolog of the
rete testis (RT), is present in the hilus of all
ovaries.1 It is composed of irregularly anasto-
mosing tubules lined by flat, cuboidal or
columnar non-ciliated cells with scanty
eosinophilic or clear cytoplasm. Some authors
state that the RO contains ciliated cells.1 The
tubules generally lack a basement membrane,
as judged by the absence of PAS staining
beneath the epithelial lining. The histological
description of RO in humans is generally sim-
ilar to that of the mouse, including a network
of irregular tubules, sometimes communicat-
ing with mesonephric tubules in the mesovar-
ium, and lined by epithelium varying from flat-
tened to columnar and occasionally ciliated.2
However, in contrast to the apparent com-
moness of cysts and tumors of the RO in mice,
these lesions are described rarely in humans.2
Lesions of the human RO have been infre-
quently described, with the largest series to
date comprising under 20 cases.3 Similarly,
there are only a few reports of benign epithe-
lial tumors of the RT.4 We describe another
rare lesion of the RO: “cystadenofibroma” of
the RO in a 75-year old female, along with a
literature review. 
Case Report
A 75-year old patient presented with sudden
onset of severe abdominal pain. Her past med-
ical and surgical history was unremarkable.
The physical examination revealed a distended
abdomen and the presence of a tender, round,
mobile right sided pelvic mass, measuring
approximately 20 cm in size. Her blood results
were within normal limits. A Computerized
Tomography (CT) scan of the abdomen and
pelvis showed a large, complex mass with solid
and cystic areas, occupying the entire pelvis.
There was a moderate amount of free fluid in
the abdomen. There was no lymphadenopathy.
The CA-125 was raised to 933 u/mL. She was
subsequently taken in for surgery. At laparoto-
my, the findings were of a large cystic mass
with smooth external surface, originating from
the right ovary and extending to the upper
abdomen. There were no adhesions to sur-
rounding organs. The rest of the pelvis and
abdominal cavity were normal. The ovarian
mass was sent for frozen section, which sug-
gested a borderline tumor. In view of this, a
staging laparotomy with total abdominal hys-
terectomy, bilateral salpingo-oophorectomy,
infracolic omentectomy and right pelvic lymph
node dissection was performed. Macrosco-
pically, a circumscribed whitish spongy mass
occupied the whole right ovary, which weighed
500 grams and measured 18x12x8 cm. The cut
surface revealed “honey-comb” like solid cystic
areas, with the cysts ranging in size from 0.2
cm to 2.5 cm and containing clear fluid (Figure
1). Microscopically, there was diffuse replace-
ment of the ovarian parenchyma, from hilus to
cortex, by a cellular proliferation of epithelial
and stromal cells (Figure 2). The epithelial
cells were arranged as tubular and slit-like
spaces (Figure 3), with numerous variably
sized cystic spaces having an irregular outline.
The tubules had an irregular branching config-
uration reminiscent of an “antler-horn” pat-
tern. The areas of prominent cystic change had
scattered tiny papillae, projecting into the cysts
(Figures 4 and 5). The cyst lumens contained
amorphous, granular, proteinaceous, eosino-
philic material along with occasional foamy
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Figure 1. Gross photograph
showing bi-valved specimen
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macrophages. The lining throughout was
bland, monolayered, non-ciliated cuboidal to
columnar, with moderate amount of pale
eosinophilic cytoplasm (Figure 6). Nuclei were
basally orientated, monomorphic, round to
oval, containing dispersed chromatin and
small nucleoli. Focally, especially in areas with
marked cystic dilatation, the lining cells were
flat. The cores of the papillae and intertubular
stroma consisted of fibrovascular tissue, con-
taining spindle-shaped cells with monomor-
phic elongated nuclei (Figure 7). Smooth mus-
cle fibers were very occasional in the stroma
(Figure 8). There were no Leydig-like cells in
the stroma, which was further confirmed by
negative immunostaining for Inhibin. Neither
nuclear atypia nor conspicuous mitotic figures
were seen in the epithelial or stromal cells.
Necrosis was not evident. Normal background
ovarian parenchyma was not seen (in spite of
embedding the whole specimen). The
labyrinthine channels, slit-like spaces and
mature fibrous mesenchymal type of stroma,
were all very reminiscent of RO. On immuno-
histochemistry, mesothelial markers (CK5/6,
Calretinin, WT-1, thrombomodulin) were nega-
tive. The epithelial lining cells were positive
for CK7, ER, PR, Vimentin and CD10 (Figures
9-12). Considering the glandular and stromal
pattern and the immunohistochemistry
results, a diagnosis of cystadenofibroma of the
RO was made. The uterus showed a benign
intramural leiomyoma along with cystic atro-
phy of the endometrium. The left ovary and
omentum were histologically unremarkable.
The right common iliac, external iliac, internal
iliac and right obturator lymph nodes showed
reactive hyperplasia only, with no evidence of
metastasis. 
Discussion
There is considerable debate regarding the
histogenesis of the RO. Most investigators
consider the RO to be of mesonephric ori-
gin.1,5-7 Upadhay et al.8 favor a mesonephric
origin in mice, but Nogales et al.8 state that
these results may not be transferable to
humans because of the considerable differ-
ences in gonadal development between
species. Nogales5 suggested that the RO repre-
sents a structure intermediate between the
mesonephric duct and ovarian sex cords.
Satoh9 elaborated how, during embryogenesis,
remnants of primordial sex cords in the basal
portion of the ovary give rise to the rete.
“Coelomic-epithelial” and “gonadal blaste-
mal” origins have also been advanced.1 Amidst
all this argument, Nogales et al.8 state that the
RO and RT are anatomical structures of uncer-
tain histogenesis. The position of the RO
varies between species. It is found most com-
Case Report
Figure 3. Microphotograph
showing variably sized irreg-






showing a markedly dilated
cyst with papillae projecting
into the cyst lumen (H&E
X200).
Figure 5. Microphotograph
showing high power view of
bland cuboidal lining of
papillae (H&E X400).
Figure 6. Microphotograph
showing bland cuboidal lin-
ing of tubules with occasion-
al ciliated cells (H&E X600).
monly in the hilus of the ovary, but may be rep-
resented by tubules or cords extending
through the medulla, or may be completely
outside the ovary, in the mesovarium, adja-
cent to the hilus.7 Age-related changes have
been described in the RO. In the human fetus,
the RO enlarges and a columnar network of
tubules extends along the length of the ovary
in the hilar regions, so that at birth, the RO is
described as strongly developed.7 The so-called
urogenital union between the rete and the
mesonephric tubules (transverse ductules in
the female, homologous with the efferent duc-
tules in the male) which was lost during the
morphogenesis of the gonad is regained in the
male to form the excretory pathway. Hence, in
males, the RT is fully developed and function-
al. On the other hand, the reunion in the
female may not occur or is imperfect,7 hence
the RO is said to be a vestigial structure of
unknown function.8,10 The RO seems to play an
important role in early gonadal embryogene-
sis, being related to primitive sex cord forma-
tion.10 From birth through puberty, the RO
comes to occupy less of the volume of the
ovary. The rete tubules become more separat-
ed by increasing amounts of connective tis-
sue. In adults, the RO is described to be vari-
able in its appearance, from almost lacking to
abundant. Though the RO is usually found
within the ovary, the position is variable and it
may be found almost completely outside in the
mesovarium. With advancing age, it tends to
become more atrophic and may become solid,
adenomatous, cystic or polycystic.7 Tumors of
the RO proper are most unusual.1,10,11 In the lit-
erature, only one report has dealt with cysts,
adenomas and carcinomas of this structure.1
Khan et al.11 have tried to explain the reason of
the comparative rarity of benign and malig-
nant tumors arising in this structure, as com-
pared to other sites in the female genital tract
(FGT). They found lower levels of estrogen
receptor (ER) and progesterone receptor (PR)
in the rete, suggesting a lesser degree of
responsiveness to hormone stimulation in
this structure, which consequently explains
the low proliferation rate in the RO. This low
proliferation rate, detected using antibody to
Ki-67, suggests a lower growth rate in this tis-
sue than in other tissues of the FGT. They
advance the theory that this low proliferation
is responsible for the rarity of RO tumors. The
major importance to recognize the RO and its
lesions is that they can be confused with other
conditions such as endometriosis.6 A detailed
description and characterization of this
unique structure (RO) may help in difficult
differential diagnoses between benign and
malignant ovarian lesions, analogous to tes-
ticular lesions.12 Recognition of benign lesions
is important so that unnecessary and poten-
tially morbid therapies are avoided.13 The
majority of the rete cysts are thought to repre-
Figure 7. Microphotograph
showing cellular fibrotic
stroma, reminiscent of rete
ovarii (H&E X200).
Figure 8. Microphotograph
showing focal smooth mus-
cle fibers (highlighted by
SMA immunostaining) in
the stroma (H&E X200).
Figure 9. Microphotograph
showing intense and diffuse
ER positivity in epithelial
cells (H & DAB X 200).
Figure 10. Microphotograph
showing intense and diffuse
CK7 positivity in epithelial
cells (H & DAB X200).
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sent non-neoplastic dilatations, since they are
lined by a single layer of bland epithelium and
appear to be exaggerations of microscopic
rete dilatations.1 Rutgers and Scully1 state that
although rete cysts have been rarely described
in the literature, they are not that uncommon.
They found 16 cases of RO cysts (cystadeno-
mas), 7 of which were found in a retrospective
review of 126 ovarian cysts. Rete cyst forma-
tion is more common in older than younger
women.1 The age range in the 16 cases
described by Rutgers and Scully1 was from 23-
80 years, (mean age 59 years), most of whom
were post-menopausal. Similarly, our case is
also that of a 75-year old post-menopausal
patient. A plethora of RT lesions have been
described,4,14 including: 
1. non-neoplastic and developmental abnor-
malities, which include rete hyperplasia,
nodular proliferation of calcifying connec-
tive tissue, cystic dysplasia, acquired or sec-
ondary cystic changes in the rete, rete
changes in cryptorchidism; 
2. benign neoplasms, which include cystade-
noma of usual type and sertoliform cystade-
noma;
3. adenocarcinoma of the rete. 
Strict criteria4 have been proposed in diag-
nosing a primary tumor of the RT, which
include: 
1. absence of histologically similar extra-scro-
tal tumor;
2. tumor centered on the testicular hilus;
3. morphology incompatible with any other
type of testicular or paratesticular tumour;
4. demonstration of a transition between the
unaffected RT and the tumor;
5. a predominantly solid appearance. 
The last criterion should not be applied too
rigidly, since although most cystic “carcino-
mas of the rete” are compatible with a serous
tumor, RT carcinomas with cystic growth pat-
tern have also been encountered. Similarly, a
transition with the unaffected RT may be dif-
ficult to demonstrate, but if all other criteria
are met, a diagnosis of a primary RT tumor is
acceptable. Although there are no such crite-
ria for diagnosing a primary tumor of the RO,
certain distinguishing features of RO tumors
have been described.1,2
They include: 
1. apparent location in the hilus of the ovary; 
2. occasional ciliated cells;
3. crevice formation of the inner surface (of
the tubules/glands) which recapitulates the
irregular outlines of the normal rete;
4. other resemblance to the normal rete;
5. normal rete adjacent to some lesions;
6. a wall of fibromuscular connective tissue.
Most of the previously reported cases have
involved the hilus alone or the hilus and part
of the medulla.1 In our case, the ovarian
involvement was diffuse and extensive, from
the hilus to the cortex. Although the definite
Case Report
Figure 11. Microphotograph
showing no staining in
epithelial cells for thrombo-
modulin (right), whereas the
normal ovarian surface
epithelial lining (left) is pos-
itive for it, acting as an inter-
nal control (H & E X200).
Figure 12. Microphotograph
showing lack of a distinct
basement membrane, high-
lighted by negative staining
for laminin (H & DAB
X400). 
Table 1. Antibodies used in the study.
Antibodies Source Dilution Type Pre-treatment Result in our case
CK5/6 Leica Pre-dilute Monoclonal ER2, 10 min - ve
ER Leica Pre-dilute Monoclonal ER2, 20 min + ve
PR Novastra 1/200 Monoclonal ER1, 20 min Patchy + ve
SMA Leica Pre-dilute Monoclonal No pre-treatment Focal + ve
Desmin Leica Pre-dilute Monoclonal ER2, 20 min Focal + ve
S100 Biogenix 1/400 Monoclonal ENZ 1, 10 min - ve
CA-125 Nocacastra 1/100 Monoclonal ER2, 20 min + ve
Cam 5.2 BD Bioscience 1/20 Monoclonal ENZ 1, 10 min + ve
EMA Dako 1/400 Monoclonal ER2, 20 min + ve
CEA Dako 1/25 Monoclonal ENZ 1, 10 min - ve
CK7 Leica Pre-dilute Monoclonal ER2, 20 min + ve
CK20 Dako 1/50 Monoclonal ER1, 20 min - ve
E-cadherin Dako 1/50 Monoclonal ER2, 20 min + ve
Vimentin Dako 1/200 Monoclonal ER1, 20 min + ve
MNF-116 Dako 1/200 Monoclonal ENZ 1, 10 min + ve
Ber-EP4 Dako 1/100 Monoclonal ENZ 1, 10 min + ve
CK19 Dako 1/200 Monoclonal ER2, 20 min + ve
Ki-67 Dako 1/200 Monoclonal ER2, 20 min < 2% cells + ve
PLAP Dako 1/50 Monoclonal ER2, 20 min - ve
CD10 Leica Pre-dilute Monoclonal ER2, 20 min + ve
Thrombomodulin Dako 1/10 Monoclonal No pre-treatment - ve
Inhibin Dako 1/100 Monoclonal ER2, 20 min - ve
Laminin Dako 1/40 Polyclonal ENZ1, 10 min - ve
WT-1 Dako 1/1000 Monoclonal ER2, 20 min - ve
AFP Dako Pre-dilute Monoclonal ER1, 10 min - ve
ER1, enzyme retrieval (low pH); ER2, enzyme retrieval (high pH); ENZ1, enzyme 1 (BondMax); ENZ2, enzyme 2 (BondMax); CK, cytokeratin;
WT, Wilms’ Tumour; ER, oestrogen receptor; PR, progesterone receptor; SMA, smooth muscle actin; EMA, epithelial membrane antigen;
CEA, carcinoembryonic antigen; PLAP, placental alkaline phosphatise; AFP, alpha feto protein.
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relation to the hilus was obscured, the cyst
walls were composed of fibrovascular tissue
with few irregularly arranged fascicles of
smooth muscle. The intervening stroma was
cellular and in places very much reminiscent
of RO. Normal ovarian tissue was not seen, in
spite of embedding and examining the whole
specimen. Similar absence of ovarian tissue
has been noted in large rete cysts of CD-1
mice.2 The possible explanations put forth by
Long2 are that ovarian tissue could have atro-
phied secondary to compression, or could have
had amyloidosis or other degenerative
changes not directly associated with the for-
mation of the cyst. Another postulated expla-
nation is that of minimal remaining ovarian
tissue, which could be missed due to limited
sectioning of the sample. But the complete
sectioning of our sample abolishes this possi-
bility. Mesonephric and rete remnants have
been described in the vicinity of the lesions in
2 cases.8 Our case also showed rete remnants
in the vicinity of the main tumor and also
admixed with it. Tumors of the RO often
exhibit stromal luteinization or Leydig-like
cells in the stroma, reproducing the normal
relations between hilar epithelial vestiges and
steroid-producing cells of the hilum.1,8,10
However, in our case, there was neither stro-
mal luteinization nor Leydig-like cells, making
the diagnosis quite difficult. Nogales et al.10
concluded that the retiform structures of
Uterine Tumor Resembling Ovarian Sex Cord
Tumor (UTROSCT) have a similar, if not iden-
tical immunophenotype to that of the RO and
the Wolffian Adnexal Tumor (WAT). They have
been regarded as different from Ovarian
Retiform Sertoli Leydig Cell Tumor (ORSLCT),
probably since these ovarian tumors seem to
recapitulate early embryogenesis reproducing
the early RO and its connection with the prim-
itive sex cords.10 Probably, they have an imma-
ture phenotype with a different antigen
expression. In our case, a number of differen-
tial diagnoses were entertained. Inclusion
cysts could not be a possibility, since firstly,
they would not be so extensive so as to replace
and involve the whole ovarian parenchyma.
Secondly, they were not stained by WT-1,
which normally stains ovarian surface epithe-
lium and ovarian inclusion cysts.15 Rete hyper-
plasia, on low power examination, reveals a
proliferation of irregularly sized anastomos-
ing channels and glands within the rete,
which do not form a circumscribed mass. The
proliferation is often vaguely lobular with
smaller glands surrounding larger cystic and
elongated forms.4 Adenomatous hyperplasia of
the rete testis (AHRT) is a benign lesion char-
acterized by solid/ glandular, papillary or crib-
riform proliferation of the epithelium with
self-limited growth. It can appear at any time
during life.14 Mesothelioma may have elongat-
ed slit-like tubules with papillary growth. But
the absence of localization within the rete, or
continuity with the RO epithelium are find-
ings that indicate a diagnosis of mesothe-
lioma, rather than RO carcinoma.4 Our case
had very bland epithelium, which was nega-
tive for mesothelial markers (calretinin,
thrombomodulin, WT-1, CK5/ 6) and positive
for epithelial markers (Cam5.2, MNF-116, Ber-
EP4). Metastatic adenocarcinoma is another
differential for RO carcinomas, though not in
our case. Bilaterality, multifocality and micro-
scopic evidence of an interstitial growth pat-
tern with lymphatic or vascular permeation
are good clues that one may be dealing with a
metastasis.4 Cystic dilatation/ transformation
of the RT has been described,4,12 but no such
entity has been described for the RO. ORSLCT
has Leydig cells (inhibin and calretinin posi-
tive) in the stroma. Positivity for inhibin and
calretinin, along with negativity for EMA and
CK7 favors the diagnosis of ORSLCT. However,
the findings in our case were the reverse: EMA
positive, inhibin and calretinin negative.
Morever, there were no Leydig cells in the
stroma. Even clinically, there were no hormon-
al manifestations in the patient. Yolk sac
tumors are known for their retiform architec-
ture.16 However, the complete absence of α
fetoprotein (AFP) in our case and the lack of
placental alkaline phosphatase (PLAP), which
occurs in about 50% of yolk sac tumors,15
makes a diagnosis of the latter most unlikely.
An ovarian adenomatoid tumor also has to be
considered in the differential diagnosis
because of some morphological features.
However, in the absence of CK5/6, calretinin
and thrombomodulin expression, such a diag-
nosis cannot be entertained. Female adnexal
tumor of probable Wolffian origin (FATWO) is
characterized by prominent tubule formation
and peritubular basement membranes.17
Laminin immunostaining accentuates a
prominent peritubular basement membrane,
and often unmasks a tubular pattern in what
may appear to be a solid proliferation.5 A reti-
form pattern may also be seen in FATWO or
WAT.9 These rare tumors are also positive for
keratins, inhibin and vimentin, with variable
ER/PR positivity. Inhibin positivity has been
reported in 68%9 and 90%9 of FATWO, but it is
patchy and weak. They are often non-reactive
for EMA.5 Although our case was positive for
vimentin, keratins and EMA, inhibin was
characteristically negative. RO has been
shown to have focal positivity for CK7, patchy
and weak staining for inhibin, 8% of cases
being positive for ER and PR.5 Our case was
diffusely positive for CK7, ER and PR, while
being negative for inhibin. EMA has been
found to be negative,5 whereas our case was
diffusely positive for EMA. Retiform uterine
tumor resembling ovarian sex cord tumor
(RUTROSCT) is another differential. But this
was not entertained in our case, since the
uterus did not show any such features.
However, RUTROSCT has been shown to have
consistent positivity for Cam5.2, CK7,
vimentin, calretinin, PR and apical CD10.
CD56 and inhibin positivity has been found in
half of the cases. EMA, desmin, SMA and
calponin have been found to be negative.10 RO
and its tumors have been found to be positive
for EMA, CA- 1256,8,10 CK7, calretinin (cytoplas-
mic), CD56 (membranous), CD10 (apical).10
They have been found to be focally positive for
vimentin and negative for CA19.9, CEA, S-100
and PR.8 However, our case was positive for
EMA, CA-125, vimentin, CK7, ER, PR, CD10,
Cam5.2, MNF-116, BerEP4, CK-19, ECadherin
and CD56. Our case was negative for WT-1,
CK5/6, calretinin, inhibin, CEA, AFP, S-100,
thrombomodulin and PLAP. Focal smooth mus-
cle in the stroma was positive for desmin and
SMA. Thus, on the basis of the histological
and immunohistochemical features of the
ovarian tumor reported here, and after exclu-
sion of other differential diagnoses, the diag-
nosis of a cystadenofibroma of the RO can be
established in this case. To summarize, to the
best of our knowledge, this is a rare case of
cystadenofibroma of the rete ovarii in a 75-
year old woman.  
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